Compounds > pyrazolanthrone
Page last updated: 2024-08-18

pyrazolanthrone and arsenic

pyrazolanthrone has been researched along with arsenic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, ST; Kim, YH; Kwon, TK; Park, EJ; Park, JW1
Chan, R; Chen, D; Jing, Y; Waxman, S1
Colombo, M; Diaz, Z; Komarnitsky, PB; Kourelis, M; Mann, KK; Marcoux, S; Miller, WH1
Hong, DY; Huang, HS; Liu, ZM1
Chen, G; Hu, Q; Jiang, S; Li, T; Mao, J; Nie, X; Wang, C; Wang, X; Xu, L; Yang, J; Zhang, Y1

Other Studies

5 other study(ies) available for pyrazolanthrone and arsenic

ArticleYear
Arsenic trioxide induces Hsp70 expression via reactive oxygen species and JNK pathway in MDA231 cells.
    Life sciences, 2005, Oct-14, Volume: 77, Issue:22

    Topics: Acetylcysteine; Anthracenes; Arsenic Trioxide; Arsenicals; Blotting, Western; Cells, Cultured; DNA Primers; DNA-Binding Proteins; Gene Expression Regulation; Heat Shock Transcription Factors; HSP70 Heat-Shock Proteins; Humans; Luciferases; MAP Kinase Kinase 4; Oxides; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transcription Factors

2005
Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors.
    Cancer research, 2006, Dec-01, Volume: 66, Issue:23

    Topics: Amino Acid Chloromethyl Ketones; Anthracenes; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Buthionine Sulfoximine; Caspase 3; Caspase Inhibitors; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Glutathione; Humans; Hydrogen Peroxide; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Leukemia; Lymphoma; Oxides; Receptors, TNF-Related Apoptosis-Inducing Ligand; Time Factors; U937 Cells

2006
A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines.
    Leukemia, 2008, Volume: 22, Issue:10

    Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Drug Resistance, Neoplasm; Glutathione; Hematologic Neoplasms; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mice; Multidrug Resistance-Associated Proteins; Oncogene Proteins, Fusion; Oxidative Stress; Oxides

2008
Blockage of JNK pathway enhances arsenic trioxide-induced apoptosis in human keratinocytes.
    Toxicology and applied pharmacology, 2010, Apr-15, Volume: 244, Issue:2

    Topics: Anthracenes; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Humans; JNK Mitogen-Activated Protein Kinases; Keratinocytes; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 8; Oxides; Phosphorylation

2010
Arsenic trioxide mediates HAPI microglia inflammatory response and subsequent neuron apoptosis through p38/JNK MAPK/STAT3 pathway.
    Toxicology and applied pharmacology, 2016, 07-15, Volume: 303

    Topics: Animals; Anthracenes; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line; Cell Line, Tumor; Humans; Imidazoles; Inflammation; Interleukin-1beta; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Microglia; Neurons; Oxides; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Rats; Signal Transduction; STAT3 Transcription Factor

2016